ClinVar Genomic variation as it relates to human health
NM_001378120.1(MBD5):c.236G>A (p.Gly79Glu)
The aggregate germline classification for this variant, typically for a monogenic or Mendelian disorder as in the ACMG/AMP guidelines, or for response to a drug. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the aggregate classification.
Stars represent the aggregate review status, or the level of review supporting the aggregate germline classification for this VCV record. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. The number of submissions which contribute to this review status is shown in parentheses.
No data submitted for somatic clinical impact
No data submitted for oncogenicity
Variant Details
- Identifiers
-
NM_001378120.1(MBD5):c.236G>A (p.Gly79Glu)
Variation ID: 198891 Accession: VCV000198891.42
- Type and length
-
single nucleotide variant, 1 bp
- Location
-
Cytogenetic: 2q23.1 2: 148463758 (GRCh38) [ NCBI UCSC ] 2: 149221327 (GRCh37) [ NCBI UCSC ]
- Timeline in ClinVar
-
First in ClinVar Help The date this variant first appeared in ClinVar with each type of classification.
Last submission Help The date of the most recent submission for each type of classification for this variant.
Last evaluated Help The most recent date that a submitter evaluated this variant for each type of classification.
Germline Apr 9, 2017 Oct 20, 2024 Apr 11, 2024 - HGVS
-
Nucleotide Protein Molecular
consequenceNM_001378120.1:c.236G>A MANE Select Help Transcripts from the Matched Annotation from the NCBI and EMBL-EBI (MANE) collaboration.
NP_001365049.1:p.Gly79Glu missense NM_018328.5:c.236G>A NP_060798.2:p.Gly79Glu missense NC_000002.12:g.148463758G>A NC_000002.11:g.149221327G>A NG_017003.2:g.447748G>A - Protein change
- G79E
- Other names
-
p.G79E:GGA>GAA
- Canonical SPDI
- NC_000002.12:148463757:G:A
-
Functional
consequence HelpThe effect of the variant on RNA or protein function, based on experimental evidence from submitters.
- -
-
Global minor allele
frequency (GMAF) HelpThe global minor allele frequency calculated by the 1000 Genomes Project. The minor allele at this location is indicated in parentheses and may be different from the allele represented by this VCV record.
-
0.00040 (A)
-
Allele frequency
Help
The frequency of the allele represented by this VCV record.
-
1000 Genomes Project 30x 0.00031
1000 Genomes Project 0.00040
Trans-Omics for Precision Medicine (TOPMed) 0.00050
The Genome Aggregation Database (gnomAD), exomes 0.00058
The Genome Aggregation Database (gnomAD) 0.00061
Exome Aggregation Consortium (ExAC) 0.00075
NHLBI Exome Sequencing Project (ESP) Exome Variant Server 0.00077
- Links
Genes
Gene | OMIM | ClinGen Gene Dosage Sensitivity Curation |
Variation Viewer
Help
Links to Variation Viewer, a genome browser to view variation data from NCBI databases. |
Related variants | ||
---|---|---|---|---|---|---|
HI score
Help
The haploinsufficiency score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
TS score
Help
The triplosensitivity score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
Within gene
Help
The number of variants in ClinVar that are contained within this gene, with a link to view the list of variants. |
All
Help
The number of variants in ClinVar for this gene, including smaller variants within the gene and larger CNVs that overlap or fully contain the gene. |
|||
MBD5 | Sufficient evidence for dosage pathogenicity | Little evidence for dosage pathogenicity |
GRCh38 GRCh37 |
1540 | 1618 |
Conditions - Germline
Condition
Help
The condition for this variant-condition (RCV) record in ClinVar. |
Classification
Help
The aggregate germline classification for this variant-condition (RCV) record in ClinVar. The number of submissions that contribute to this aggregate classification is shown in parentheses. (# of submissions) |
Review status
Help
The aggregate review status for this variant-condition (RCV) record in ClinVar. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. |
Last evaluated
Help
The most recent date that a submitter evaluated this variant for the condition. |
Variation/condition record
Help
The RCV accession number, with most recent version number, for the variant-condition record, with a link to the RCV web page. |
---|---|---|---|---|
Likely benign (2) |
criteria provided, multiple submitters, no conflicts
|
Feb 5, 2024 | RCV000188125.21 | |
no classifications from unflagged records (1) |
no classifications from unflagged records
|
Oct 26, 2023 | RCV000455290.11 | |
Benign/Likely benign (4) |
criteria provided, multiple submitters, no conflicts
|
Apr 11, 2024 | RCV000470089.31 | |
Benign/Likely benign (4) |
criteria provided, multiple submitters, no conflicts
|
Mar 1, 2024 | RCV000712260.32 | |
Likely benign (1) |
criteria provided, single submitter
|
Dec 14, 2021 | RCV002314674.9 | |
MBD5-related disorder
|
Likely benign (1) |
no assertion criteria provided
|
Nov 19, 2021 | RCV003907633.2 |
Submissions - Germline
Classification
Help
The submitted germline classification for each SCV record. (Last evaluated) |
Review status
Help
Stars represent the review status, or the level of review supporting the submitted (SCV) record. This value is calculated by NCBI based on data from the submitter. Read our rules for calculating the review status. This column also includes a link to the submitter’s assertion criteria if provided, and the collection method. (Assertion criteria) |
Condition
Help
The condition for the classification, provided by the submitter for this submitted (SCV) record. This column also includes the affected status and allele origin of individuals observed with this variant. |
Submitter
Help
The submitting organization for this submitted (SCV) record. This column also includes the SCV accession and version number, the date this SCV first appeared in ClinVar, and the date that this SCV was last updated in ClinVar. |
More information
Help
This column includes more information supporting the classification, including citations, the comment on classification, and detailed evidence provided as observations of the variant by the submitter. |
|
---|---|---|---|---|---|
Likely benign
(Oct 21, 2015)
|
criteria provided, single submitter
Method: clinical testing
|
not specified
Affected status: no
Allele origin:
germline
|
Genetic Services Laboratory, University of Chicago
Accession: SCV000247908.2
First in ClinVar: Oct 05, 2015 Last updated: Nov 10, 2017 |
|
|
Likely benign
(Apr 13, 2018)
|
criteria provided, single submitter
Method: clinical testing
|
not provided
Affected status: unknown
Allele origin:
germline
|
Athena Diagnostics
Accession: SCV000842706.1
First in ClinVar: Oct 20, 2018 Last updated: Oct 20, 2018 |
|
|
Benign
(Oct 02, 2019)
|
criteria provided, single submitter
Method: clinical testing
|
Not Provided
Affected status: yes
Allele origin:
germline
|
GeneDx
Accession: SCV000241732.8
First in ClinVar: Aug 07, 2015 Last updated: Jul 24, 2021 |
Comment:
This variant is associated with the following publications: (PMID: 27222293, 21981781, 23055267)
|
|
Likely benign
(Dec 14, 2021)
|
criteria provided, single submitter
Method: clinical testing
|
Inborn genetic diseases
Affected status: unknown
Allele origin:
germline
|
Ambry Genetics
Accession: SCV000847582.5
First in ClinVar: Nov 08, 2018 Last updated: May 01, 2024 |
Comment:
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of … (more)
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. (less)
|
|
Benign
(Apr 11, 2024)
|
criteria provided, single submitter
Method: clinical testing
|
Intellectual disability, autosomal dominant 1
Affected status: unknown
Allele origin:
maternal
|
Mayo Clinic Laboratories, Mayo Clinic
Accession: SCV000782477.2
First in ClinVar: Jul 07, 2018 Last updated: May 01, 2024 |
Comment:
BS1, BS2, BS4
|
|
Likely benign
(May 28, 2019)
|
criteria provided, single submitter
Method: clinical testing
|
Intellectual disability, autosomal dominant 1
Affected status: unknown
Allele origin:
unknown
|
Mendelics
Accession: SCV001135962.1
First in ClinVar: Jan 09, 2020 Last updated: Jan 09, 2020 |
|
|
Likely benign
(Jan 22, 2024)
|
criteria provided, single submitter
Method: clinical testing
|
Intellectual disability, autosomal dominant 1
Affected status: unknown
Allele origin:
germline
|
Labcorp Genetics (formerly Invitae), Labcorp
Accession: SCV000557165.9
First in ClinVar: Apr 17, 2017 Last updated: Feb 20, 2024 |
|
|
Likely Benign
(Feb 05, 2024)
|
criteria provided, single submitter
Method: clinical testing
|
not specified
Affected status: unknown
Allele origin:
germline
|
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Accession: SCV004847439.1
First in ClinVar: Apr 20, 2024 Last updated: Apr 20, 2024 |
Comment:
The p.Gly79Glu variant in MBD5 is classified as likely benign because it has been identified in 0.1% (75/68004) of European chromosomes by gnomAD (http://gnomad.broadinstitute.org, v.3.1.2). … (more)
The p.Gly79Glu variant in MBD5 is classified as likely benign because it has been identified in 0.1% (75/68004) of European chromosomes by gnomAD (http://gnomad.broadinstitute.org, v.3.1.2). ACMG/AMP Criteria applied: BS1. (less)
|
|
Likely benign
(Mar 01, 2024)
|
criteria provided, single submitter
Method: clinical testing
|
not provided
Affected status: yes
Allele origin:
germline
|
CeGaT Center for Human Genetics Tuebingen
Accession: SCV004042083.11
First in ClinVar: Oct 14, 2023 Last updated: Oct 20, 2024 |
Comment:
MBD5: BS1
Number of individuals with the variant: 5
|
|
Likely benign
(Nov 19, 2021)
|
no assertion criteria provided
Method: clinical testing
|
MBD5-related condition
Affected status: unknown
Allele origin:
germline
|
PreventionGenetics, part of Exact Sciences
Accession: SCV004727682.2
First in ClinVar: Mar 16, 2024 Last updated: Oct 08, 2024 |
Comment:
This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).
|
|
Uncertain significance
(Jan 16, 2018)
|
Flagged submission
flagged submission
Method: clinical testing
Reason: Outlier claim with insufficient supporting evidence
Source: ClinGen
|
not provided
Affected status: unknown
Allele origin:
germline
|
Eurofins Ntd Llc (ga)
Accession: SCV000232763.5
First in ClinVar: Jun 29, 2015 Last updated: Dec 15, 2018 |
Number of individuals with the variant: 7
Sex: mixed
|
|
Likely pathogenic
(Oct 01, 2012)
|
Flagged submission
flagged submission
Method: research
Reason: Outlier claim with insufficient supporting evidence
Source: ClinGen
|
MBD5 associated neurodevelopmental disorder
Affected status: yes
Allele origin:
de novo
|
Elsea Laboratory, Baylor College of Medicine
Accession: SCV000264475.1
First in ClinVar: Apr 09, 2017 Last updated: Apr 09, 2017 |
Number of individuals with the variant: 1
|
|
Uncertain significance
(May 23, 2017)
|
Flagged submission
flagged submission
Method: clinical testing
Reason: Outlier claim with insufficient supporting evidence
Source: ClinGen
|
Intellectual disability, autosomal dominant 1
Affected status: unknown
Allele origin:
unknown
|
Fulgent Genetics, Fulgent Genetics
Accession: SCV000611479.1
First in ClinVar: Apr 17, 2017 Last updated: Apr 17, 2017 |
|
|
click to load more click to collapse | |||||
Flagged submissions do not contribute to the aggregate classification or review status for the variant. Learn more |
Germline Functional Evidence
There is no functional evidence in ClinVar for this variation. If you have generated functional data for this variation, please consider submitting that data to ClinVar. |
Citations for germline classification of this variant
HelpTitle | Author | Journal | Year | Link |
---|---|---|---|---|
Clinical and Molecular Aspects of MBD5-Associated Neurodevelopmental Disorder (MAND). | Mullegama SV | European journal of human genetics : EJHG | 2016 | PMID: 27222293 |
Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. | Richards S | Genetics in medicine : official journal of the American College of Medical Genetics | 2015 | PMID: 25741868 |
The expanding role of MBD genes in autism: identification of a MECP2 duplication and novel alterations in MBD5, MBD6, and SETDB1. | Cukier HN | Autism research : official journal of the International Society for Autism Research | 2012 | PMID: 23055267 |
Assessment of 2q23.1 microdeletion syndrome implicates MBD5 as a single causal locus of intellectual disability, epilepsy, and autism spectrum disorder. | Talkowski ME | American journal of human genetics | 2011 | PMID: 21981781 |
http://www.egl-eurofins.com/emvclass/emvclass.php?approved_symbol=MBD5 | - | - | - | - |
Text-mined citations for rs34995577 ...
HelpRecord last updated Nov 03, 2024
This date represents the last time this VCV record was updated. The update may be due to an update to one of the included submitted records (SCVs), or due to an update that ClinVar made to the variant such as adding HGVS expressions or a rs number. So this date may be different from the date of the “most recent submission” reported at the top of this page.